Chiang, A. S., Loblaw, D. A., Jethava, V., Sethukavalan, P., Zhang, L., Vesprini, D., . . . Klotz, L. (2013). Utility of 5-alpha-reductase inhibitors in active surveillance for favourable risk prostate cancer. Canadian Medical Association.
استشهاد بنمط شيكاغوChiang, Andrew S., D. Andrew Loblaw, Vibhuti Jethava, Perakaa Sethukavalan, Liying Zhang, Danny Vesprini, Alexandre Mamedov, Robert Nam, و Laurence Klotz. Utility of 5-alpha-reductase Inhibitors in Active Surveillance for Favourable Risk Prostate Cancer. Canadian Medical Association, 2013.
MLA استشهادChiang, Andrew S., et al. Utility of 5-alpha-reductase Inhibitors in Active Surveillance for Favourable Risk Prostate Cancer. Canadian Medical Association, 2013.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.